Patient Preferences on Participation in Chronic Obstructive Pulmonary Disease Practice-based Research in a Community Pharmacy Setting
1Director of the University of Tennessee’s PGY1 Community Pharmacy Residency Program, and Director of Community Affairs, Department of Clinical Pharmacy, University of Tennessee Health Science Center, 193 Polk Ave, Suite 2D, Nashville, TN 37210, USA
- *Corresponding Author:
- Kenneth C. Hohmeier
Assistant Professor, Director of the University of Tennessee’s
PGY1 Community Pharmacy Residency Program
and Director of Community Affairs
Department of Clinical Pharmacy
University of Tennessee Health Science Center
193 Polk Ave, Suite 2D, Nashville
TN 37210, USA
E-mail: [email protected]
Received date: January 24, 2016; Accepted date: January 30, 2016; Published date: February 06, 2016
Citation: Hohmeier KC, Masselink A (2016) Patient Preferences on Participation in Chronic Obstructive Pulmonary Disease Practice-based Research in a Community Pharmacy Setting. J App Pharm 8:214. doi: 10.4172/1920-4159.1000214
Copyright: © 2016 Hohmeier KC, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Objective: To investigate patient preferences on community pharmacist-led practice-based research to inform the development of a multi-site, practice-based research protocol.
Methods: Paper surveys were administered at the point-of-care to patients eligible to participate in a COPD disease state management (DSM) program. Eligibility was determined based on fill history and the survey was completed anonymously. Descriptive statistics are reported.
Results: A total of 22 individuals were recruited to participate during the five months of data collection, and 12 participated (55% response rate). When asked if their pharmacist could play a role in improving the patient’s COPD control, 92% of patients agreed or strongly agreed. A majority of patients (92%,) agreed that they would be interested in participating in pharmacist-led COPD research study that lasted at most 6 months, with 75% of patients agreeing to meet with the pharmacist up to 30 minutes during each appointment.
Conclusions: This patient perceptions study demonstrated that the majority of COPD patients were willing to participate in pharmacy research at their local community pharmacy and viewed a reasonable length of study duration of 6 months with 30 minutes per pharmacy visit.